PUBLICATIONS

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Alan Miller , Kenneth D. Candido , Nebojsa Nick Knezevic , Jos ´e Rivera , Paul Lunseth , Dennis J. Levinson , Ferdinand Formoso , Daneshvari Solanki , Edward Tavel , Angela Krull , Richard Radnovich , Daniel Burkhead , Dmitri Souza, Standiford Helm, Nathaniel Katz , Robert H. Dworkin , Steven P. Cohen , James P. Rathmell , Asokumar Buvanendran , Joshua Levin , Elizabeth Stannard , Chris Ambrose , Mark Jaros , Kip Vought , Dmitri Lissin

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

PUBLICATIONS

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch

Topical Delivery Systems Effectively Transport Analgesics to Areas of Localized Pain via Direct Diffusion

Review of Multimodal Therapies for the Treatment of Neuropathic Pain: Clinical Implications

Impact of Adhesion on Patient Satisfaction, Medication Switching and Discontinuation With Lidocaine Topical Patches Based on FDA Adverse Event Reporting and Patient Surveys

Decreased Healthcare Resource Utilization With Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Pain Freedom With Celecoxib Oral Solution, Ubrogepant, and Rimegepant Through 4 Hours Postdose: Post Hoc Analysis in the Acute Treatment of Migraine

Detection and Adjustment for Participant Response Effects in a 2-Period, Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Oral Solution for the Acute Treatment of Migraine

Results from a Pivotal Phase 3, DB, R, Placebo-controlled, Multicenter Trial of SP-102, a Novel Dexamethasone Injectable Formulation, for the Treatment of Patients with Lumbosacral Radiculopathy (Sciatica)

Results from a Pivotal Phase 3, DB, R, Placebo-controlled, Multicenter Trial of SP-102, a Novel Dexamethasone Injectable Formulation, for the Treatment of Patients with Lumbosacral Radiculopathy (Sciatica)

Corporate Presentation

Safety of Epidural Steroid Injections for Lumbosacral Radicular Pain

A Randomized, Crossover, Pharmacokinetic and Adhesion Performance Study of a Lidocaine Topical System 1.8% During Physical Activity and Heat Treatment in Healthy Subjects

Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System

Repeat Epidural Injections of SP-102 (Dexamethasone Sodium Phosphate Injectable Gel) in Subjects with Lumbosacral Radiculopathy

Open-label adhesion performance studies of a new lidocaine topical system 1.8% versus lidocaine patches 5% and lidocaine medicated plaster 5% in healthy subjects.

Characteristics of Analgesic Patch Formulations.

A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects

A Randomized, Crossover, Adhesion Performance and Pharamcokinetic Study of a Lidocaine Topical System Under Conditions of Water Exposure in Healthy Subjects.

Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.

Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia

Email Alert